Clinical Trials Directory

Trials / Unknown

UnknownNCT01666964

Hormone Deficiency After Brain Injury During Combat

Prevalence of Hypopituitarism Following Combat-related Traumatic Brain Injury in a Military Population

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Walter Reed National Military Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We would like to ascertain the prevalence of hypopituitarism after combat-related TBI. This will lead to enhanced awareness, recognition, and treatment of hypopituitarism, which can have life-saving ramifications and enhance quality of life and rehabilitation efforts in our combat veterans.

Detailed description

The prevalence of hypopituitarism after combat-related traumatic brain injury (TBI) is currently unknown. Recent civilian data on TBI show the prevalence of any pituitary hormone deficiency is as high as 80% after 12 months. While the military prevalence of hypopituitarism can be extrapolated from civilian data, a major limitation is the notably different mechanism of injury (i.e., blast) for military personnel compared to civilians (i.e., assaults, traffic accidents and falls). Little is known about the effect of shockwaves from a blast injury on central nervous system tissue, and due to the unique nature of blast-related TBI, the prevalence of pituitary dysfunction in affected service members may significantly differ from nonmilitary subjects in prior studies.

Conditions

Interventions

TypeNameDescription
OTHERBlast Traumatic Brain InjuryExposure during combat to blast-wave mediated Traumatic Brain Injury

Timeline

Start date
2012-10-01
Primary completion
2014-12-01
Completion
2015-05-01
First posted
2012-08-16
Last updated
2012-08-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01666964. Inclusion in this directory is not an endorsement.